Literature DB >> 23054508

Self-report measurement of lower urinary tract symptoms: a commentary on the literature since 2011.

James W Griffith1.   

Abstract

Self-report assessment of lower urinary tract symptoms (LUTS) is complicated by the many tools that are available. The International Prostate Symptom Score (IPSS) is widely used and highly recommended in review articles and practice guidelines. This review focuses on work completed since 2011 using the IPSS and other tools. The focus of the review is on the merits and weakness of existing tools, as well as a discussion of how to move the field forward, given that there is already a strong base of questionnaires. Some specific trends in health measurement include the use of item response theory and computer adaptive testing, but it is unclear to what extent they will be adopted within urology. Many current studies in urology are making use of single items to assess important symptoms of interest, such as nocturia and incontinence, so future work might seek to catalogue best-in-class, single-question items.

Entities:  

Mesh:

Year:  2012        PMID: 23054508     DOI: 10.1007/s11934-012-0286-5

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   3.092


  38 in total

1.  The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association.

Authors:  M J Barry; F J Fowler; M P O'Leary; R C Bruskewitz; H L Holtgrewe; W K Mebust; A T Cockett
Journal:  J Urol       Date:  1992-11       Impact factor: 7.450

2.  Epidemiology of stress urinary incontinence in women.

Authors:  W Stuart Reynolds; Roger R Dmochowski; David F Penson
Journal:  Curr Urol Rep       Date:  2011-10       Impact factor: 3.092

3.  Nocturia associated with depressive symptoms.

Authors:  Timothy V Johnson; Ammara Abbasi; Samantha S Ehrlich; Renee S Kleris; Charles L Raison; Viraj A Master
Journal:  Urology       Date:  2011-01       Impact factor: 2.649

4.  Effect of bothersome overactive bladder symptoms on health-related quality of life, anxiety, depression, and treatment seeking in the United States: results from EpiLUTS.

Authors:  Ian Milsom; Steven A Kaplan; Karin S Coyne; Chris C Sexton; Zoe S Kopp
Journal:  Urology       Date:  2012-07       Impact factor: 2.649

5.  Patient reported incontinence after radical prostatectomy is more common than expected and not associated with the nerve sparing technique: results from the Center for Prostate Disease Research (CPDR) database.

Authors:  Andrew C Peterson; Yongmei Chen
Journal:  Neurourol Urodyn       Date:  2011-08-08       Impact factor: 2.696

6.  Reliability and responsiveness of the Urgency Severity and Life Impact Questionnaire (USIQ).

Authors:  Lior Lowenstein; Leslie Rickey; Kimberly Kenton; Mary P Fitzgerald; Linda Brubaker; Mary Tulke; Joye Fordham; Elizabeth R Mueller
Journal:  Int Urogynecol J       Date:  2011-08-18       Impact factor: 2.894

7.  Nocturia is associated with an increased risk of coronary heart disease and death.

Authors:  Deborah J Lightner; Amy E Krambeck; Debra J Jacobson; Michaela E McGree; Steven J Jacobsen; Michael M Lieber; Véronique L Roger; Cynthia J Girman; Jennifer L St Sauver
Journal:  BJU Int       Date:  2012-01-10       Impact factor: 5.588

8.  Test-retest reliability of four questionnaires for patients with overactive bladder: the overactive bladder questionnaire (OAB-q), patient perception of bladder condition (PPBC), urgency questionnaire (UQ), and the primary OAB symptom questionnaire (POSQ).

Authors:  Louis S Matza; Christine L Thompson; Joel Krasnow; Jessica Brewster-Jordan; Teresa Zyczynski; Karin S Coyne
Journal:  Neurourol Urodyn       Date:  2005       Impact factor: 2.696

9.  The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: results from the EPIC study.

Authors:  Karin S Coyne; Chris C Sexton; Debra E Irwin; Zoe S Kopp; Con J Kelleher; Ian Milsom
Journal:  BJU Int       Date:  2008-06       Impact factor: 5.588

10.  ICIQ: a brief and robust measure for evaluating the symptoms and impact of urinary incontinence.

Authors:  Kerry Avery; Jenny Donovan; Tim J Peters; Christine Shaw; Momokazu Gotoh; Paul Abrams
Journal:  Neurourol Urodyn       Date:  2004       Impact factor: 2.696

View more
  5 in total

1.  A New Brief Clinical Assessment of Lower Urinary Tract Symptoms for Women and Men: LURN SI-10.

Authors:  David Cella; Abigail R Smith; James W Griffith; Ziya Kirkali; Kathryn E Flynn; Catherine S Bradley; J Eric Jelovsek; Brenda W Gillespie; Brian T Helfand; Pooja Talaty; Kevin P Weinfurt
Journal:  J Urol       Date:  2019-07-31       Impact factor: 7.450

Review 2.  Identifying and classifying quality of life tools for neurogenic bladder function after spinal cord injury: A systematic review.

Authors:  Krista L Best; Karen Ethans; B Catharine Craven; Luc Noreau; Sander L Hitzig
Journal:  J Spinal Cord Med       Date:  2016-10-13       Impact factor: 1.985

3.  Integrated Item Response Theory Modeling of Multiple Patient-Reported Outcomes Assessing Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia.

Authors:  Yassine Kamal Lyauk; Trine Meldgaard Lund; Andrew C Hooker; Mats O Karlsson; Daniël M Jonker
Journal:  AAPS J       Date:  2020-07-29       Impact factor: 4.009

4.  Bounded Integer Modeling of Symptom Scales Specific to Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia.

Authors:  Yassine Kamal Lyauk; Daniël M Jonker; Andrew C Hooker; Trine Meldgaard Lund; Mats O Karlsson
Journal:  AAPS J       Date:  2021-02-25       Impact factor: 4.009

5.  Item Response Theory Modeling of the International Prostate Symptom Score in Patients with Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia.

Authors:  Yassine Kamal Lyauk; Daniël M Jonker; Trine Meldgaard Lund; Andrew C Hooker; Mats O Karlsson
Journal:  AAPS J       Date:  2020-08-27       Impact factor: 4.009

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.